Paper7540952
The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth.
Pili R and 5 others. Cancer Res, 1995. Cited by 151 papers, by iCite.
Cite this record
ConductScience Library. The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth. Papers, record 7540952. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7540952
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth.
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endothelium | Major topic |
| Glycoconjugates | Major topic |
| Glycoside Hydrolase Inhibitors | Major topic |
| Glycosylation | Major topic |
| Indolizines | Major topic |
| Neoplasms, Experimental | Major topic |
| Neovascularization, Pathologic | Major topic |
| 1-Deoxynojirimycin | |
| Animals | |
| Cell Adhesion | |
| Cell Aggregation | |
| Cell Differentiation | |
| Cell Division | |
| Cells, Cultured | |
| Chemotaxis | |
| Glucosamine | |
| Growth Inhibitors | |
| In Vitro Techniques | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Nude | |
| Protein Processing, Post-Translational | |
| Indolizidines |
Source PubMed
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 151 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42762413 | Integrative multi-omics analysis identifies LIPA as a prognostic hub and ferroptosis regulator in lung adenocarcinoma. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/42762413 | PubMed |
| 41286166 | Design, synthesis, pharmacological evaluation and computational modeling of 4-formyl-2-nitrophenyl quinoline-8-sulfonate derived thiosemicarbazones as antidiabetic agents. | J Comput Aided Mol Des | 2025 | https://conductscience.org/library/papers/41286166 | PubMed |
| 40891620 | Domino Grignard Addition/Cope-House Reaction for the Synthesis of Polyhydroxylated 3-Methylindolizidines Analogous to Castanospermine. | Org Lett | 2025 | https://conductscience.org/library/papers/40891620 | PubMed |
| 40661216 | Synthesis and multi-target antiproliferative evaluation of novel 1,2,4-triazole-3-thione analogues against breast cancer: in silico and in vitro mechanistic insights. | RSC Adv | 2025 | https://conductscience.org/library/papers/40661216 | PubMed |
| 39595931 | Enzyme (α-Glucosidase, α-Amylase, PTP1B & VEGFR-2) Inhibition and Cytotoxicity of Fluorinated Benzenesulfonic Ester Derivatives of the 5-Substituted 2-Hydroxy-3-nitroacetophenones. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39595931 | PubMed |
| 39456508 | Exploring the 3,5-Dibromo-4,6-dimethoxychalcones and Their Flavone Derivatives as Dual α-Glucosidase and α-Amylase Inhibitors with Antioxidant and Anticancer Potential. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39456508 | PubMed |
| 39098853 | Glycosylation: mechanisms, biological functions and clinical implications. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39098853 | PubMed |
| 38982268 | Design, synthesis, in vitro, and in silico anti-α-glucosidase assays of N-phenylacetamide-1,2,3-triazole-indole-2-carboxamide derivatives as new anti-diabetic agents. | Sci Rep | 2024 | https://conductscience.org/library/papers/38982268 | PubMed |
| 38362162 | BIRTH OF A GLYCOTHERAPY FOR BREAST CANCER. | Trends Carbohydr Res | 2023 | https://conductscience.org/library/papers/38362162 | PubMed |
| 38001824 | In Vitro α-Glucosidase and α-Amylase Inhibition, Cytotoxicity and Free Radical Scavenging Profiling of the 6-Halogeno and Mixed 6,8-Dihalogenated 2-Aryl-4-methyl-1,2-dihydroquinazoline 3-Oxides. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/38001824 | PubMed |
| 37623885 | Deciphering Molecular Aspects of Potential α-Glucosidase Inhibitors within Aspergillus terreus: A Computational Odyssey of Molecular Docking-Coupled Dynamics Simulations and Pharmacokinetic Profiling. | Metabolites | 2023 | https://conductscience.org/library/papers/37623885 | PubMed |
| 36282858 | Peptide Lv augments intermediate-conductance calcium-dependent potassium channels (KCa3.1) in endothelial cells to promote angiogenesis. | PLoS One | 2022 | https://conductscience.org/library/papers/36282858 | PubMed |
| 35732907 | Design, synthesis, in vitro α-glucosidase inhibition, docking, and molecular dynamics of new phthalimide-benzenesulfonamide hybrids for targeting type 2 diabetes. | Sci Rep | 2022 | https://conductscience.org/library/papers/35732907 | PubMed |
| 35731990 | Deepening the knowledge of rare diseases dependent on angiogenesis through semantic similarity clustering and network analysis. | Brief Bioinform | 2022 | https://conductscience.org/library/papers/35731990 | PubMed |
| 35454076 | Glycotherapy: A New Paradigm in Breast Cancer Research. | Biomolecules | 2022 | https://conductscience.org/library/papers/35454076 | PubMed |
| 35002739 | Elevated N-Glycosylation Contributes to the Cisplatin Resistance of Non-Small Cell Lung Cancer Cells Revealed by Membrane Proteomic and Glycoproteomic Analysis. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/35002739 | PubMed |
| 33303737 | Inhibition of protein glycosylation is a novel pro-angiogenic strategy that acts via activation of stress pathways. | Nat Commun | 2020 | https://conductscience.org/library/papers/33303737 | PubMed |
| 33209651 | Nanoformulation enhances anti-angiogenic efficacy of tunicamycin. | Transl Cancer Res | 2013 | https://conductscience.org/library/papers/33209651 | PubMed |
| 33092246 | Evaluation of Cytotoxicity and α-Glucosidase Inhibitory Activity of Amide and Polyamino-Derivatives of Lupane Triterpenoids. | Molecules | 2020 | https://conductscience.org/library/papers/33092246 | PubMed |
| 31698979 | Newly Identified Peptide, Peptide Lv, Promotes Pathological Angiogenesis. | J Am Heart Assoc | 2019 | https://conductscience.org/library/papers/31698979 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7540952
GET https://conductscience.org/api/papers/v1/7540952/cited_by?page=2